Oral and inhaled corticosteroids: Differences in P-glycoprotein (ABCB1) mediated efflux

There is concern that P-glycoprotein mediated efflux contributes to steroid resistance. Therefore, this study examined bidirectional corticosteroid transport and induction capabilities for P-glycoprotein (P-gp) to understand which of the systemic and inhaled corticosteroids interacted with P-gp to t...

Full description

Bibliographic Details
Main Authors: Crowe, Andrew, Tan, A.
Format: Journal Article
Published: Elsevier 2012
Online Access:http://hdl.handle.net/20.500.11937/21050
_version_ 1848750482337562624
author Crowe, Andrew
Tan, A.
author_facet Crowe, Andrew
Tan, A.
author_sort Crowe, Andrew
building Curtin Institutional Repository
collection Online Access
description There is concern that P-glycoprotein mediated efflux contributes to steroid resistance. Therefore, this study examined bidirectional corticosteroid transport and induction capabilities for P-glycoprotein (P-gp) to understand which of the systemic and inhaled corticosteroids interacted with P-gp to the greatest extent. Hydrocortisone, prednisolone, prednisone, methylprednisolone, and dexamethasone represented systemically active drugs, while fluticasone propionate, beclomethasone dipropionate, ciclesonide and budesonide represented inhaled corticosteroids. Aldosterone and fludrocortisone represented mineralocorticoids. All drugs were detected using individually optimised HPLC protocols. Transport studies were conducted through Caco-2 monolayers. Hydrocortisone and aldosterone had efflux ratios below 1.5, while prednisone showed a P-gp mediated efflux ratio of only 1.8 compared to its active drug, prednisolone, with an efflux ratio of 4.5. Dexamethasone and beclomethasone had efflux ratios of 2.1 and 3.3 respectively, while this increased to 5.1 for methylprednisolone. Fluticasone showed an efflux ratio of 2.3. Protein expression studies suggested that all of the inhaled corticosteroids were able to induce P-gp expression, from 1.6 to 2 times control levels. Most of the systemic corticosteroids had higher passive permeability (>20×10−6 cm/s) compared to the inhaled corticosteroids (>5×10−6 cm/s), except for budesonide, with permeability similar to the systemic corticosteroids. Inhaled corticosteroids are not transported by P-gp to the same extent as systemic corticosteroids. However, they are able to induce P-gp production. Thus, inhaled corticosteroids may have greater interactions with other P-gp substrates, but P-gp itself is less likely to influence resistance to the drugs.
first_indexed 2025-11-14T07:37:32Z
format Journal Article
id curtin-20.500.11937-21050
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T07:37:32Z
publishDate 2012
publisher Elsevier
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-210502017-09-13T16:08:12Z Oral and inhaled corticosteroids: Differences in P-glycoprotein (ABCB1) mediated efflux Crowe, Andrew Tan, A. There is concern that P-glycoprotein mediated efflux contributes to steroid resistance. Therefore, this study examined bidirectional corticosteroid transport and induction capabilities for P-glycoprotein (P-gp) to understand which of the systemic and inhaled corticosteroids interacted with P-gp to the greatest extent. Hydrocortisone, prednisolone, prednisone, methylprednisolone, and dexamethasone represented systemically active drugs, while fluticasone propionate, beclomethasone dipropionate, ciclesonide and budesonide represented inhaled corticosteroids. Aldosterone and fludrocortisone represented mineralocorticoids. All drugs were detected using individually optimised HPLC protocols. Transport studies were conducted through Caco-2 monolayers. Hydrocortisone and aldosterone had efflux ratios below 1.5, while prednisone showed a P-gp mediated efflux ratio of only 1.8 compared to its active drug, prednisolone, with an efflux ratio of 4.5. Dexamethasone and beclomethasone had efflux ratios of 2.1 and 3.3 respectively, while this increased to 5.1 for methylprednisolone. Fluticasone showed an efflux ratio of 2.3. Protein expression studies suggested that all of the inhaled corticosteroids were able to induce P-gp expression, from 1.6 to 2 times control levels. Most of the systemic corticosteroids had higher passive permeability (>20×10−6 cm/s) compared to the inhaled corticosteroids (>5×10−6 cm/s), except for budesonide, with permeability similar to the systemic corticosteroids. Inhaled corticosteroids are not transported by P-gp to the same extent as systemic corticosteroids. However, they are able to induce P-gp production. Thus, inhaled corticosteroids may have greater interactions with other P-gp substrates, but P-gp itself is less likely to influence resistance to the drugs. 2012 Journal Article http://hdl.handle.net/20.500.11937/21050 10.1016/j.taap.2012.03.008 Elsevier restricted
spellingShingle Crowe, Andrew
Tan, A.
Oral and inhaled corticosteroids: Differences in P-glycoprotein (ABCB1) mediated efflux
title Oral and inhaled corticosteroids: Differences in P-glycoprotein (ABCB1) mediated efflux
title_full Oral and inhaled corticosteroids: Differences in P-glycoprotein (ABCB1) mediated efflux
title_fullStr Oral and inhaled corticosteroids: Differences in P-glycoprotein (ABCB1) mediated efflux
title_full_unstemmed Oral and inhaled corticosteroids: Differences in P-glycoprotein (ABCB1) mediated efflux
title_short Oral and inhaled corticosteroids: Differences in P-glycoprotein (ABCB1) mediated efflux
title_sort oral and inhaled corticosteroids: differences in p-glycoprotein (abcb1) mediated efflux
url http://hdl.handle.net/20.500.11937/21050